Results 131 to 140 of about 76,320 (330)
Morphine combined with doxapram or naloxone* [PDF]
, 1974 Pranav Gupta, J. W. Dundee
openalex +1 more source
Drug and Alcohol Review, EarlyView.ABSTRACT Introduction A group of synthetic opioids, the nitazenes, is appearing in the illicit drug market. Monitoring these novel psychoactive substances is challenging due to constantly evolving analogues and the small amounts of these potent drugs that are consumed.
Emma L. Keller +6 more
wiley +1 more source
Naloxone-induced aversion to sucrose in morphine-dependent rats [PDF]
, 1975 Joseph W. Ternes
openalex +1 more source
Drug and Alcohol Review, EarlyView.ABSTRACT Introduction The unregulated drug supply in the United States is rapidly evolving, and veterinary tranquillisers have emerged as adulterants of concern, especially in illicitly‐manufactured fentanyl. Following the proliferation of xylazine, medetomidine, a more potent sedative, has recently appeared in multiple US states.
Adams L. Sibley +6 more
wiley +1 more source
Behavioural Effects and Naloxone Effectiveness With New Synthetic Opioids
Drug and Alcohol Review, EarlyView.ABSTRACT Introduction The global drug market has seen an emergence of potent synthetic opioids, including benzimidazole‐derived substances known as nitazenes. These compounds have been implicated in fatal and non‐fatal overdoses. This review aims to synthesise current evidence on the pharmacological effects, potency and naloxone responsiveness of new ...
Suzanne Nielsen +8 more
wiley +1 more source
Beta-Adrenergic Receptor Blockade By Propranolol Enhances Retention In A Multitrial Passive-Avoidance Procedure [PDF]
, 2000 The effect of beta -adrenergic receptor blockade on retention in a mildly aversive passive-avoidance procedure was investigated. Rats were given passive-avoidance training-1 trial per day for 4 days-and were administered saline, the centrally and ...
Koven, Nancy, , \u2798 +4 more
core +1 more source
Naloxone prescription fills and use by patients treated for opioid use disorder by telehealth
Drug and Alcohol Dependence ReportsBackground: It is unknown how many people in treatment for opioid use disorder (OUD) have naloxone, use naloxone, and what their perceptions and barriers to obtaining it are.
Scott G. Weiner +3 more
doaj +1 more source
Economic Inquiry, EarlyView.Abstract In their 2022 study, ‘The Effects of Naloxone Access Laws on Opioid Abuse, Mortality, and Crime,’ Doleac and Mukherjee conclude that broadening access to a life‐saving drug—naloxone—does not reduce opioid‐related mortality as the drug simultaneously encourages riskier drug use. I show issues with their data, design, and estimation methods. For
Sergey Alexeev
wiley +1 more source
Journal of Advanced Nursing, EarlyView.ABSTRACT Aim To explore the key knowledge, skills, attributes and organisational support that nurses require to optimise their scope of practice when providing care to people experiencing homelessness. Design A qualitative descriptive study exploring nurses' scope of practice for addressing health needs of people experiencing homelessness.
Olivia Hollingdrake +4 more
wiley +1 more source